167 related articles for article (PubMed ID: 31437604)
1. CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
Puchert M; Obst J; Koch C; Zieger K; Engele J
Cytokine; 2020 Jan; 125():154809. PubMed ID: 31437604
[TBL] [Abstract][Full Text] [Related]
2. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
Koch C; Fischer NC; Puchert M; Engele J
BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.
Singh AK; Arya RK; Trivedi AK; Sanyal S; Baral R; Dormond O; Briscoe DM; Datta D
Cytokine Growth Factor Rev; 2013 Feb; 24(1):41-9. PubMed ID: 22989616
[TBL] [Abstract][Full Text] [Related]
4. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
5. Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.
Mir H; Kapur N; Singh R; Sonpavde G; Lillard JW; Singh S
Cell Cycle; 2016; 15(6):819-26. PubMed ID: 27029529
[TBL] [Abstract][Full Text] [Related]
6. Role of I-TAC-binding receptors CXCR3 and CXCR7 in proliferation, activation of intracellular signaling pathways and migration of various tumor cell lines.
Miekus K; Jarocha D; Trzyna E; Majka M
Folia Histochem Cytobiol; 2010 Jan; 48(1):104-11. PubMed ID: 20529825
[TBL] [Abstract][Full Text] [Related]
7. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration.
Proost P; Mortier A; Loos T; Vandercappellen J; Gouwy M; Ronsse I; Schutyser E; Put W; Parmentier M; Struyf S; Van Damme J
Blood; 2007 Jul; 110(1):37-44. PubMed ID: 17363734
[TBL] [Abstract][Full Text] [Related]
9. The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection.
Torraca V; Cui C; Boland R; Bebelman JP; van der Sar AM; Smit MJ; Siderius M; Spaink HP; Meijer AH
Dis Model Mech; 2015 Mar; 8(3):253-69. PubMed ID: 25573892
[TBL] [Abstract][Full Text] [Related]
10. Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts.
Lau TS; Chung TK; Cheung TH; Chan LK; Cheung LW; Yim SF; Siu NS; Lo KW; Yu MM; Kulbe H; Balkwill FR; Kwong J
J Pathol; 2014 Jan; 232(1):43-56. PubMed ID: 24014111
[TBL] [Abstract][Full Text] [Related]
11. CXCL11-CXCR3 Axis Mediates Tumor Lymphatic Cross Talk and Inflammation-Induced Tumor, Promoting Pathways in Head and Neck Cancers.
Kumaravel S; Singh S; Roy S; Venkatasamy L; White TK; Sinha S; Glaser SS; Safe SH; Chakraborty S
Am J Pathol; 2020 Apr; 190(4):900-915. PubMed ID: 32035061
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
14. Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells.
Li H; Rong S; Chen C; Fan Y; Chen T; Wang Y; Chen D; Yang C; Yang J
Mol Carcinog; 2019 Feb; 58(2):171-184. PubMed ID: 30302818
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding.
Cox JH; Dean RA; Roberts CR; Overall CM
J Biol Chem; 2008 Jul; 283(28):19389-99. PubMed ID: 18411283
[TBL] [Abstract][Full Text] [Related]
16. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
[TBL] [Abstract][Full Text] [Related]
17. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
18. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
Shin SY; Nam JS; Lim Y; Lee YH
J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
[TBL] [Abstract][Full Text] [Related]
19. Oxaliplatin inhibits colorectal cancer progression by inhibiting CXCL11 secreted by cancer-associated fibroblasts and the CXCR3/PI3K/AKT pathway.
Lu C; Zhang C
Clin Transl Oncol; 2023 Jan; 25(1):160-172. PubMed ID: 36129606
[TBL] [Abstract][Full Text] [Related]
20. CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways.
Berchiche YA; Sakmar TP
Mol Pharmacol; 2016 Oct; 90(4):483-95. PubMed ID: 27512119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
